CDE Catalog

View and download available CureSCi CDEs using filters below. For best results, clear form between searches.

Displaying 51 - 75 of 4213
Operations
Selected 25 rows in this page.  
The search results below can be downloaded by clicking the checkboxes on the far right side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
CDE ID CDE Name Definition Classification Version Number Version Date CRF Name ©, ® or TM Disease Name Sub Disease Name
C01565 Blood pressure systolic measurement

Measurement of pressure of the participant's/subject's blood against the artery walls during systole (the contraction phase) in millimeters of mercury (mmHg)

Proposed 3.00 2013-07-25 08:54:08.2 Vital Signs Sickle Cell Disease Sickle Cell Disease
C01580 Temperature unit of measure

Unit of measure for the temperature numerical value

Proposed 3.00 2013-07-24 11:38:01.2 Vital Signs Sickle Cell Disease Sickle Cell Disease
C01581 Weight unit of measure

Unit of measure for the weight numerical value

Proposed 3.00 2013-07-25 08:54:08.2 Vital Signs Sickle Cell Disease Sickle Cell Disease
C01582 Height unit of measure

Unit of measure for the height numerical value for subject/participant

Proposed 3.00 2013-07-24 11:38:01.2 Vital Signs Sickle Cell Disease Sickle Cell Disease
C01701 Lab specimen collection date and time

Date (and time if applicable and known) when the specimen was collected

Proposed 3.00 2013-07-25 08:54:08.2 Hematopoiesis Form Sickle Cell Disease Sickle Cell Disease
C01711 Lab test result unit of measure

Unit of measure for the laboratory test result

Proposed 3.00 2013-07-25 08:54:08.2 PhenX Toolkit: N-terminal Pro-brain Natriuretic Peptide (NT-proBNP) level Sickle Cell Disease Sickle Cell Disease
C02200 Last study intervention date and time

Date (and time, if applicable) of the last known study intervention that the participant/subject received

Proposed 3.00 2013-07-18 16:35:19.49 Study Discontinuation/Completion Sickle Cell Disease Sickle Cell Disease
C02201 Off study intervention prematurely indicator

Indicator that participant/subject discontinued study intervention before planned end of study

Proposed 3.00 2013-07-20 10:21:25.65 Study Discontinuation/Completion Sickle Cell Disease Sickle Cell Disease
C02202 Off study date and time

Date (and time, if applicable and known) when participant/subject completes study or is prematurely withdrawn from study (i.e., is not being followed and will not receive intervention/treatment)

Proposed 3.00 2013-07-18 14:26:06.9 Study Discontinuation/Completion Sickle Cell Disease Sickle Cell Disease
C02203 Off study reason

Primary reason participant/ subject is no longer participating in study (i.e., is not being followed and will not receive intervention/treatment).

Proposed 3.00 2013-07-18 16:35:19.49 Study Discontinuation/Completion Sickle Cell Disease Sickle Cell Disease
C02222 Off study intervention prematurely reason

Primary reason participant/subject discontinued study intervention before planned end of study

Proposed 3.00 2013-07-20 10:21:25.65 Study Discontinuation/Completion Sickle Cell Disease Sickle Cell Disease
C02300 Adverse event study intervention action taken type

Type of action taken for adverse event in relation to study intervention

Proposed 3.00 2013-07-18 16:35:19.49 Adverse Events Sickle Cell Disease Sickle Cell Disease
C02301 Adverse event end date and time

Date (and time, if applicable and known) on which the adverse event discontinued/stopped

Proposed 3.00 2013-07-18 16:35:19.49 Adverse Events Sickle Cell Disease Sickle Cell Disease
C02302 Adverse event other action taken type

Type of action taken due to adverse event other than action taken with study intervention/ treatment

Proposed 3.00 2013-07-22 09:34:41.527 Adverse Events Sickle Cell Disease Sickle Cell Disease
C02303 Adverse event outcome status

Final status of the participant/subject related to the adverse event

Proposed 3.00 2013-07-22 09:34:41.527 Adverse Events Sickle Cell Disease Sickle Cell Disease
C02304 Adverse event relatedness scale

Scale of the causality between the treatment modality/intervention and the specific adverse event

Proposed 3.00 2013-07-18 16:35:19.49 Adverse Events Sickle Cell Disease Sickle Cell Disease
C02305 Adverse event severity grade scale

The grading scale of the severity or intensity of the adverse event

Proposed 4.00 2013-07-22 09:34:41.527 Adverse Events Sickle Cell Disease Sickle Cell Disease
C02306 Adverse event start date and time

Date (and time, if applicable and known) on which the adverse event was first evident

Proposed 3.00 2013-07-18 16:35:19.49 Adverse Events Sickle Cell Disease Sickle Cell Disease
C02307 Adverse event verbatim term text

Text that describes the adverse event word for word as described by the participant/subject

Proposed 3.00 2013-07-18 16:35:19.49 Adverse Events Sickle Cell Disease Sickle Cell Disease
C02308 Adverse event during study indicator

Indicator of whether the participant/subject experienced any adverse events during the study

Proposed 3.00 2013-07-18 16:35:19.49 Adverse Events Sickle Cell Disease Sickle Cell Disease
C02309 Serious adverse event indicator

The indicator of whether the adverse event is serious.

Proposed 3.00 2013-08-28 16:08:00.453 Adverse Events Sickle Cell Disease Sickle Cell Disease
C02310 Adverse event CTCAE low level term name

Text that represents the Common Terminology Criteria for Adverse Events (CTCAE) low level term name for an adverse event.

Proposed 3.00 2013-08-28 16:08:00.453 Adverse Events Sickle Cell Disease Sickle Cell Disease
C02311 Adverse event MedDRA lower level term code

Code that corresponds to the Medical Dictionary for Regulatory Activities (MedDRA) Lower Level Term (LLT) for an adverse event

Proposed 3.00 2013-07-18 16:35:19.49 Adverse Events Sickle Cell Disease Sickle Cell Disease
C02411 Laterality type

Laterality type relative to the anatomic site of the body examined or affected

Proposed 3.00 2013-08-28 16:08:00.453 NIH Stroke Scale (NIHSS) Sickle Cell Disease Sickle Cell Disease
C02411 Laterality type

Laterality type relative to the anatomic site of the body examined or affected

Proposed 3.00 2013-08-28 16:08:00.453 Neurological Exam Sickle Cell Disease Sickle Cell Disease
Displaying 51 - 75 of 4213